SCHEMBL4677364

SCHEMBL4677364

Oc1cccc(-c2ccc(Oc3ccc(-c4cccc(O)c4)cc3)cc2)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 10/20 0.74
HSD17B2 P37059 9/20 0.74
CYP3A4 P08684 3/20 0.74
CYP2C9 P11712 2/20 0.74
ESR1 P03372 5/20 0.61
ESR2 Q92731 4/20 0.61
CYP1A2 P05177 1/20 0.61
CYP2D6 P10635 1/20 0.61
CYP2B6 P20813 1/20 0.61
CYP2C19 P33261 1/20 0.61
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
ABL1 P00519 1/20 0.52
ABCB1 P08183 1/20 0.52
BCR P11274 1/20 0.52
KDM1A O60341 2/20 0.49
CYP17A1 P05093 1/20 0.49
CYP19A1 P11511 1/20 0.49
CYP11B1 P15538 1/20 0.49
CYP11B2 P19099 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4674827 0.96 HSD17B1 (0.76) HSD17B1HSD17B2CYP3A4CYP2C9ESR1
SCHEMBL19542210 0.94 HSD17B1 (0.65) HSD17B1HSD17B2CYP3A4CYP2C9ESR1
SCHEMBL9292956 0.91 HSD17B1 (0.68) HSD17B1HSD17B2CYP3A4CYP2C9ESR1
SCHEMBL8069693 0.87 CYP3A4 (0.54) HSD17B1HSD17B2CYP3A4CYP2C9ESR1
SCHEMBL2090901 0.86 ABL1 (0.57) HSD17B1HSD17B2CYP3A4CYP2C9ESR1
SCHEMBL2089768 0.86 HSD17B1 (0.55) HSD17B1HSD17B2CYP3A4CYP2C9ESR1
SCHEMBL7898375 0.86 HSD17B1 (1.00) HSD17B1HSD17B2CYP3A4CYP2C9ESR1
SCHEMBL21311926 0.86 HSD17B1 (0.61) HSD17B1HSD17B2CYP3A4CYP2C9ESR1
SCHEMBL5842072 0.84 HSD17B1 (0.62) HSD17B1HSD17B2CYP3A4CYP2C9ESR1
SCHEMBL2093379 0.84 HSD17B1 (0.57) HSD17B1HSD17B2CYP3A4CYP2C9ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6881815-B2 Method for the preparation poly(etherimide)s GENERAL ELECTRIC COMPANY (US) 2005-04-19 US claimed
EP-1458791-A1 METHODS FOR THE PREPARATION OF POLY(ETHERIMIDES)S GENERAL ELECTRIC COMPANY (US) 2004-09-22 EP claimed
US-20040063897-A1 Method for the preparation poly(etherimide)s SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2004-04-01 US claimed
US-6590108-B1 Transimidation of bis(imide) in presence of phthalic anhydride having substituent selected from group consisting of nitro, bromo, fluoro and chloro, to yield dianhydride GENERAL ELECTRIC COMPANY 2003-07-08 US claimed
WO-2003050165-A1 METHODS FOR THE PREPARATION OF POLY(ETHERIMIDES)S GENERAL ELECTRIC COMPANY (US) 2003-06-19 WO claimed
US-6498224-B1 SOLUTION POLYMERIZATION OF A DIANHYDRIDE AND A DIAMINE WHICH ELIMINATES THE NITRATION STEP; HIGH HEAT ENGINEERING PLASTICS GENERAL ELECTRIC COMPANY 2002-12-24 US claimed
EP-1403303-B1 Methods for the preparation of poly(etherimide)s GEN ELECTRIC (US) 2008-08-20 EP disclosed
EP-1458791-B1 METHODS FOR THE PREPARATION OF POLY(ETHERIMIDES)S GEN ELECTRIC (US) 2006-11-29 EP disclosed
US-6881815-B2 Method for the preparation poly(etherimide)s GENERAL ELECTRIC COMPANY (US) 2005-04-19 US disclosed
EP-1458791-A1 METHODS FOR THE PREPARATION OF POLY(ETHERIMIDES)S GENERAL ELECTRIC COMPANY (US) 2004-09-22 EP disclosed
US-20040063897-A1 Method for the preparation poly(etherimide)s SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2004-04-01 US disclosed
EP-1403303-A1 Methods for the preparation of poly(etherimide)s General Electric Company (US) 2004-03-31 EP disclosed
US-6590108-B1 Transimidation of bis(imide) in presence of phthalic anhydride having substituent selected from group consisting of nitro, bromo, fluoro and chloro, to yield dianhydride GENERAL ELECTRIC COMPANY 2003-07-08 US disclosed
WO-2003050165-A1 METHODS FOR THE PREPARATION OF POLY(ETHERIMIDES)S GENERAL ELECTRIC COMPANY (US) 2003-06-19 WO disclosed
US-6498224-B1 SOLUTION POLYMERIZATION OF A DIANHYDRIDE AND A DIAMINE WHICH ELIMINATES THE NITRATION STEP; HIGH HEAT ENGINEERING PLASTICS GENERAL ELECTRIC COMPANY 2002-12-24 US disclosed
US-5466392-A Organic electroluminescence device and compound having an aluminum complex structure IDEMITSU KOSAN CO., LTD. (JP) 1995-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063897-A1 Method for the preparation poly(etherimide)s FHIT, PBRM1, PMAIP1 HSD17B1 2281/4885HSD17B2 2364/4885CYP3A4 1074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.